Can congenital heart disease be treated in a 3-month-old baby?

Congenital heart disease in 3-month-old babies can be treated, including medication, surgery and interventional therapy. The specific plan depends on the severity and type of the disease. Congenital heart disease is caused by abnormal heart development during the embryonic period, which may be related to genetics, environmental factors, maternal infection or drug use.

1. Drug treatment: For babies with mild symptoms, doctors may prescribe drugs to relieve symptoms or improve heart function. For example, diuretics such as furosemide can reduce the burden on the heart, beta-blockers such as propranolol can reduce heart rate, and digoxin can enhance myocardial contractility. Drug treatment is usually used as an auxiliary means and must be used under the guidance of a doctor.

2. Surgical treatment: For babies with more serious conditions, surgery is the main treatment method. Common surgeries include heart defect repair, patent ductus arteriosus ligation and tetralogy of Fallot correction. The timing and method of surgery should be determined according to the specific situation of the baby, and it is usually performed after the baby's physical condition stabilizes.

3. Interventional therapy: Interventional therapy is a minimally invasive surgery that is suitable for certain types of congenital heart disease. For example, atrial septal defect closure and patent ductus arteriosus closure can be completed through catheter technology, which is less invasive and has a quick recovery. Interventional therapy needs to be performed in a professional hospital, and the doctor will assess whether it is suitable based on the condition.

The treatment of congenital heart disease requires multidisciplinary collaboration, including pediatric cardiologists, cardiac surgeons, and anesthesiologists. Parents should actively cooperate with doctors in treatment, conduct regular follow-up visits, and monitor the baby's heart function and quality of life. Early diagnosis and timely treatment can significantly improve the baby's prognosis and quality of life.